Mutations in DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes. (April 2017) - Cedena, M.T.; Rapado, I.; Santos-Lozano, A.; Ayala, R.; Onecha, E.; Abáigar, M.; Such, E.; Ramos, F.; Cervera, J.V.; Sanz, G.; Hernández-Rivas, J.M.; Lucía, A.; et al.